AU2020273321A1 - Compositions and methods for treating the eye - Google Patents

Compositions and methods for treating the eye Download PDF

Info

Publication number
AU2020273321A1
AU2020273321A1 AU2020273321A AU2020273321A AU2020273321A1 AU 2020273321 A1 AU2020273321 A1 AU 2020273321A1 AU 2020273321 A AU2020273321 A AU 2020273321A AU 2020273321 A AU2020273321 A AU 2020273321A AU 2020273321 A1 AU2020273321 A1 AU 2020273321A1
Authority
AU
Australia
Prior art keywords
optionally
pichia
extracts
composition
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020273321A
Other languages
English (en)
Inventor
Mingqi Bai
Kenneth T. Holeva
Wen-Hwa Ting LI
Khalid Mahmood
Ramine Parsa
Manpreet Randhawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Johnson and Johnson Surgical Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/099,185 external-priority patent/US11969451B2/en
Application filed by Johnson and Johnson Surgical Vision Inc filed Critical Johnson and Johnson Surgical Vision Inc
Publication of AU2020273321A1 publication Critical patent/AU2020273321A1/en
Assigned to Johnson & Johnson Surgical Vision, Inc. reassignment Johnson & Johnson Surgical Vision, Inc. Request for Assignment Assignors: JOHNSON & JOHNSON CONSUMER INC.
Priority to AU2022263530A priority Critical patent/AU2022263530A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2020273321A 2019-11-19 2020-11-19 Compositions and methods for treating the eye Abandoned AU2020273321A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2022263530A AU2022263530A1 (en) 2019-11-19 2022-11-03 Compositions and methods for treating the eye

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962937473P 2019-11-19 2019-11-19
US201962937458P 2019-11-19 2019-11-19
US62/937,473 2019-11-19
US62/937,458 2019-11-19
US17/099,185 US11969451B2 (en) 2019-11-19 2020-11-16 Compositions and methods for treating the eye
US17/099,185 2020-11-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022263530A Division AU2022263530A1 (en) 2019-11-19 2022-11-03 Compositions and methods for treating the eye

Publications (1)

Publication Number Publication Date
AU2020273321A1 true AU2020273321A1 (en) 2021-06-03

Family

ID=75964158

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2020273321A Abandoned AU2020273321A1 (en) 2019-11-19 2020-11-19 Compositions and methods for treating the eye
AU2022263530A Pending AU2022263530A1 (en) 2019-11-19 2022-11-03 Compositions and methods for treating the eye

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2022263530A Pending AU2022263530A1 (en) 2019-11-19 2022-11-03 Compositions and methods for treating the eye

Country Status (6)

Country Link
JP (1) JP2021080253A (ko)
KR (1) KR20210061297A (ko)
CN (1) CN112933118A (ko)
AU (2) AU2020273321A1 (ko)
BR (1) BR102020023560A8 (ko)
CA (1) CA3100032A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117268877B (zh) * 2023-11-21 2024-02-20 军科正源（北京）药物研究有限责任公司 检测人泪液中的神经生长因子的方法及其泪液的处理方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1883469B (zh) * 2006-05-26 2011-07-20 武汉远大制药集团有限公司 一种含有维生素a和维生素e的眼用微乳及其制备方法
NZ591391A (en) * 2008-10-22 2012-10-26 Quark Pharmaceuticals Inc Non-invasive methods for treating eye disorders using a topical oligonucleotide composition
US20170128357A1 (en) * 2015-11-06 2017-05-11 Johnson & Johnson Consumer Inc. Topical gel cream composition
US20170172913A1 (en) * 2015-12-17 2017-06-22 Johnson & Johnson Consumer Inc. Topical Compositions Comprising Pichia Anomala and Chicory Root Extracts
ITUB20160543A1 (it) * 2016-02-08 2017-08-08 Sooft Italia S P A 63833 Montegiorgio Fermo / Italia Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali
US10206870B2 (en) * 2016-12-12 2019-02-19 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract

Also Published As

Publication number Publication date
KR20210061297A (ko) 2021-05-27
CN112933118A (zh) 2021-06-11
AU2022263530A1 (en) 2022-12-08
BR102020023560A2 (pt) 2021-10-13
BR102020023560A8 (pt) 2023-02-07
CA3100032A1 (en) 2021-05-19
JP2021080253A (ja) 2021-05-27

Similar Documents

Publication Publication Date Title
US11357805B2 (en) Compositions and methods for treating the eye
AU2022246418B2 (en) Compositions and methods for treating the eye
US11878042B2 (en) Compositions and methods for treating the eye
US11878041B2 (en) Compositions and methods for treating the eye
EP3824895A1 (en) Compositions and methods for treating the eye
US20210186913A1 (en) Compositions and methods for treating the eye
AU2022263530A1 (en) Compositions and methods for treating the eye
US11969451B2 (en) Compositions and methods for treating the eye
EP3824877A1 (en) Compositions and methods for treating the eye
RU2795913C2 (ru) Композиции и способы лечения глаз
RU2793736C2 (ru) Композиции и способы лечения глаз
RU2792627C2 (ru) Композиции и способы лечения глаз
RU2802625C2 (ru) Композиции и способы лечения глаз

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: JOHNSON & JOHNSON SURGICAL VISION, INC.

Free format text: FORMER APPLICANT(S): JOHNSON & JOHNSON CONSUMER INC.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted